z-logo
open-access-imgOpen Access
Dosimetric evaluation of incidental irradiation to the axilla during whole breast radiotherapy for patients with left-sided early breast cancer in the IMRT era
Author(s) -
Jayoung Lee,
Shin-Wook Kim,
Seung Hyun Son
Publication year - 2016
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000004036
Subject(s) - medicine , axilla , breast cancer , radiation therapy , nuclear medicine , radiology , cancer
The purpose of this study was to compare the dosimetric parameters for incidental irradiation to the axilla during whole breast radiotherapy (WBRT) with 3-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT). Twenty left breast cancer patients treated with WBRT after breast-conserving surgery (BCS) were enrolled in this study. Remnant breast tissue, 3 levels of the axilla, heart, and lung were delineated. We used 2 different radiotherapy methods: 3D-CRT with field-in-field technique and 7-field fixed-beam IMRT. The target coverage of IMRT was significantly better than that of 3D-CRT ( D mean : 49.72 ± 0.64 Gy vs 50.24 ± 0.66 Gy, P  < 0.001; V 45 : 93.19 ± 1.40% vs 98.59 ± 0.30%, P  < 0.001; V 47.5 : 86.43 ± 2.72% vs 95.00 ± 0.02%, P  < 0.001, for 3D-CRT and IMRT, respectively). In the IMRT plan, a lower dose was delivered to a wider region of the heart and lung. Significantly lower axillary irradiation was shown throughout each level of axilla by IMRT compared to 3D-CRT ( D mean for level I: 42.58 ± 5.31 Gy vs 14.49 ± 6.91 Gy, P  < 0.001; D mean for level II: 26.25 ± 10.43 Gy vs 3.41 ± 3.11 Gy, P  < 0.001; D mean for level III: 6.26 ± 4.69 Gy vs 1.16 ± 0.51 Gy, P  < 0.001; D mean for total axilla: 33.9 ± 6.89 Gy vs 9.96 ± 5.21 Gy, P  < 0.001, for 3D-CRT and IMRT, respectively). In conclusion, the incidental dose delivered to the axilla was significantly lower for IMRT compared to 3D-CRT. Therefore, IMRT, which only includes the breast parenchyma, should be cautiously used in patients with limited positive sentinel lymph nodes and who do not undergo complete axillary lymph node dissection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here